Mayo Clinic
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Location contact
Robert Frantz, M.D.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06751082
The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Robert Frantz, M.D.
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline, Year 1, Year 2, Year 3, Year 4, Year 5, Year 6, Year 7, Year 8, Year 9, Year 10
The EmPHasis10 Questionnaire consists of 10 questions to assess quality of life. The scores can range from 0-50, a higher score indicates a worse quality of life.
Time frame: Baseline, Year 10
Pulmonary hypertension vasodilator medications are used to decrease pressure in the pulmonary arteries.
Time frame: Baseline, Year 10
A change in dose of prostanoid medications will be determined by a change from baseline dosage.
Time frame: Baseline, Year 10
Number of patient hospitalizations will be determined by the number of patients admitted into the hospital.
Time frame: Baseline, Year 10
Cease of therapy session will be determined by a patient's termination of all therapy sessions
Time frame: Baseline, Year 10
Number of patients to discontinue prostanoid therapy will be determined by a patients termination of all prostanoid therapy
Time frame: Baseline, Year 10
Bleeding complications include nosebleeds not requiring ER visit or transfusion, epistaxis or GI hemorrhage requiring ED visit/hospitalization.
Time frame: Baseline, Year 10
Development of skin telangiectasias includes new development, worsening, or distribution
Time frame: Baseline, Year 10
6 minute walk distance will be measured in meters (m).
Time frame: Baseline, Year 10
Change in hemodynamics include the change in Blood Flow, Blood Pressure, Cardiac Output, Vascular Resistance, Perfusion
Time frame: Baseline, Year 10
Right Ventricular Systolic Pressure is the pressure in the right ventricle during contraction. RVSP will be measured in mmHg.
Time frame: Baseline, Year 10
Right Ventricular Strain refers to strain on the right ventricle during contraction. Right Ventricular Strain will be determined by echocardiogram and measured as a percentage.
Time frame: Baseline, Year 10
Change in RV function will be determined by echocardiogram and measured as a percentage.
Time frame: Baseline, Year 10
Capacitance is the ability for blood vessels to store and release blood. capacitance will be determined by echocardiogram.
Time frame: Baseline, Year 10
Tricuspid regurgitation is the regurgitation of blood into the right atrium during contraction of the heart.
Time frame: Baseline, Year 10
Stroke Volume is calculated by End-Diastolic Volume (EDV)-End-Systolic Volume (ESV) and measured in mL
Time frame: Baseline, Year 10
Pulse Pressure is calculated by PP=systolic blood pressure (SBP) - diastolic blood pressure (DBP) and measured in mmHg
Time frame: Baseline, Year 10
Functional class refers to the severity of patients heart condition. A change in class would refer to the increase or decrease in severity of the condition.
Time frame: Baseline, Year 10
A transplant is defined as receiving an organ or tissue from a donor.
Contact information is provided by the study sponsor or research team.
Hayden Halbach, M.B.A.
CONTACT
Louise Durst, R.N.
CONTACT
Mayo Clinic
Other
Sotatercept Pulmonary Hypertension Observational Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07561034
Cardiovascular Diseases, Hypertension
Rochester, New York, United States
View Trial DetailsNCT06336798
Cardiovascular Diseases, Hypertension
Atlanta, Georgia, United States
View Trial DetailsNCT01730092
Cardiovascular Diseases, Hypertension
Bethesda, Maryland, United States
View Trial DetailsNCT07214376
Cardiovascular Diseases, Heart Diseases
Houma, Louisiana, United States
View Trial Details